In Bearbeitung
Lektion 1, Thema 1
In Bearbeitung

Responsibilities II

THE DRUGS AND SAFETY COMMITTEE

  • Identifying new medicines risks and updating the Safe and Secure Handling, Administration and Supply of Medicines POLICY and Safe and Secure Handling, Administration and Supply of Medicines STANDARD accordingly.
  • Ensuring that the health and safety of patients, public and staff are given primary consideration when implementing or altering processes, programs, locations, or physical facilities related to medicines and carrying out risk assessments should be carried out as appropriate.
  • Ensure that all Adverse Event ( AE) SOP for Pharmacovigilance Officer Adverse Event Reporting and Product Quality Complaints (PQC) SOP for Handling Product Quality Complaints are recorded according to the set SOP’s. 
  • Establish assurance arrangements for the Safe and Secure Handling, Administration and Supply of Medicines.
  • Continually improve practice through review and analysis of data.

CLINICAL GOVERNANCE COMMITTEE

The Clinical Governance Committee is responsible for:

  • Approving this Policy and associated Safe and Secure Handling, Administration and Supply of Medicines STANDARD
  • Managing and approving exceptions and variations to the Policy and Standard.
  • Establish assurance arrangements for the Safe and Secure Handling, Administration and Supply of Medicines.
  • Continually improve practice through review and analysis of data.

HEALTH AND SAFETY

  • Ensuring that the health and safety of patients, public and staff are given primary consideration when implementing or altering processes, programs, locations, or physical facilities related to medicines and carrying out risk assessments should be carried out as appropriate.
  • Advise Managers on Health and Safety concerns.